STRS Ohio’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$706K Buy
22,100
+4,000
+22% +$132K ﹤0.01% 945
2026
Q1
$693K Buy
18,100
+17,400
+2,486% +$563K ﹤0.01% 851
2025
Q4
$18.4K Hold
700
﹤0.01% 2110
2025
Q3
$9.79K Hold
700
﹤0.01% 2158
2025
Q2
$6.7K Hold
700
﹤0.01% 2174
2025
Q1
$6.51K Hold
700
﹤0.01% 1890
2024
Q4
$9.73K Hold
700
﹤0.01% 1847
2024
Q3
$16.5K Hold
700
﹤0.01% 1902
2024
Q2
$11.2K Hold
700
﹤0.01% 1917
2024
Q1
$11K Buy
+700
New +$11.5K ﹤0.01% 1878
2022
Q1
Sell
-2,800
Closed -$39K 2240
2021
Q4
$39K Buy
+2,800
New +$55.6K ﹤0.01% 2038

Other funds holding TYRA

STRS Ohio's TYRA Position: Q2 2026 in Review

STRS Ohio increased its Tyra Biosciences (TYRA) stake by 22% in Q2 2026, buying an estimated $132K and bringing the position to 22,100 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

STRS Ohio first reported a position in TYRA in Q4 2021 and has held it in 11 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • STRS Ohio held 22,100 shares of Tyra Biosciences worth $706K as of Q2 2026.
  • STRS Ohio bought 4,000 Tyra Biosciences shares in Q2 2026, an estimated $132K.
  • Tyra Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #945 holding.
  • STRS Ohio first reported a position in Tyra Biosciences in Q4 2021 and has held it in 11 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.